N-substituted-2-aminoquinolines useful for treating hypofunction

Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544128, 544242, 544333, 544405, 546163, C07D40102

Patent

active

057707340

ABSTRACT:
##STR1## wherein R.sup.1 is H, alkyl or cycloalkyl of 1 to 6 carbon atoms;

REFERENCES:
patent: 2534774 (1950-12-01), Jacob et al.
patent: 3576804 (1971-04-01), Stauffer
patent: 4203988 (1980-05-01), Bolhofer
patent: 4840972 (1989-06-01), Effland et al.
patent: 4916135 (1990-04-01), Effland et al.
Marx, Science, vol. 250, 1989 pp. 1509-1510.
Thompson, et al., New England J. Medicine 323(7) 1990, pp. 445-448.
Molchan et al., Drug Research Reviews 17(1992) 215-226.
Bartus, et al. Science 217, 1982, pp. 408-417.
Marx, et al., Science 243, 1989 pp. 1664-1666.
Moos et al., Med. Res. Rev. 8(3) 353-391 (1988).
Whitehouse et al. Ann. Neurobiol., 1981, pp. 122-126, vol. 10(2).
Whitehouse, Advances in Bah. Biology, 29, 1985, pp. 85-94.
Collarton, Neuroscience, 19(1), pp. 1-28, 1986 Henderson Acta Psychiatr. Scand. 1988:78 257-275.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N-substituted-2-aminoquinolines useful for treating hypofunction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-substituted-2-aminoquinolines useful for treating hypofunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted-2-aminoquinolines useful for treating hypofunction will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1395651

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.